These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10483287)

  • 21. Mortality risk with sulphonylureas compared to metformin.
    Holden SE; Currie CJ
    Diabetes Obes Metab; 2014 Oct; 16(10):885-90. PubMed ID: 24533964
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin and type 2 diabetes. Last resort or rational management?
    Holmwood C; Philips P
    Aust Fam Physician; 1999 May; 28(5):429-35. PubMed ID: 10376366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Triple oral therapy in type 2 diabetes].
    Scheen AJ
    Rev Med Suisse; 2005 Aug; 1(30):1942, 1944-6, 1948. PubMed ID: 16200937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Better blood glucose control. Extending metformin dosage].
    MMW Fortschr Med; 2001 Sep; 143(38):59. PubMed ID: 11601099
    [No Abstract]   [Full Text] [Related]  

  • 25. Follow-up of intensive glucose control in type 2 diabetes.
    Mühlhauser I
    N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674
    [No Abstract]   [Full Text] [Related]  

  • 26. Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
    Aquilante CL; Zhang W; McCollum M
    Curr Med Res Opin; 2007 Mar; 23(3):489-94. PubMed ID: 17355730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dose-response relation between sulfonylurea drugs and mortality in type 2 diabetes mellitus: a population-based cohort study.
    Simpson SH; Majumdar SR; Tsuyuki RT; Eurich DT; Johnson JA
    CMAJ; 2006 Jan; 174(2):169-74. PubMed ID: 16415461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin initiation in Type 2 diabetes.
    Page S
    Diabet Med; 2005 Sep; 22 Suppl 4():2-5. PubMed ID: 16109011
    [No Abstract]   [Full Text] [Related]  

  • 29. [Metformin. Mode of action and effect of monotherapy and combination therapy on glucose metabolism in type 2 diabetes].
    Christiansen AL; Madsbad S
    Ugeskr Laeger; 2002 Apr; 164(15):2025-8. PubMed ID: 11985000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of efficacy and safety of fixed dose combination of glimepiride 2 mg pluspioglitazone 15 mg plus metformin SR 500 mg in the management of patients with type-2 diabetes mellitus.
    Meshram DM; Langade DG; Kinagi SB; Naikwadi AA; Morye V; Chopra D
    J Indian Med Assoc; 2005 Aug; 103(8):447-50. PubMed ID: 16363204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sulfonylurea therapy is associated with increased NT-proBNP levels in the treatment of type 2 diabetes.
    Tildesley HD; Aydin CM; Ignaszewski A; Strelzow JA; Yu E; Bondy G
    Int J Cardiol; 2007 Feb; 115(3):312-7. PubMed ID: 16824633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of a new oral drug in the treatment of diabetes mellitus].
    Lubetzki J
    Diabete; 1971; 19(3):185-90. PubMed ID: 5002990
    [No Abstract]   [Full Text] [Related]  

  • 33. [Chlorpropamide-metformin in obese diabetics or diabetics with side effects from sulfonylureas. 2-year results].
    Garcia Viveros M; Prado Vega R; Rull JA; Lozano-Castañeda O
    Prensa Med Mex; 1971; 36(7):347-9. PubMed ID: 5096256
    [No Abstract]   [Full Text] [Related]  

  • 34. [Combination insulin and sulfonylurea compounds in the therapy of type II diabetes mellitus].
    Diem P
    Schweiz Med Wochenschr; 1990 Jul; 120(27-28):987-8. PubMed ID: 2197718
    [No Abstract]   [Full Text] [Related]  

  • 35. Control of blood sugar level in elderly diabetic patients.
    Davis PJ; Davis FB
    Prim Care; 1982 Mar; 9(1):45-51. PubMed ID: 7041153
    [No Abstract]   [Full Text] [Related]  

  • 36. Preoperative Continuation Versus Interruption of Oral Hypoglycemics in Type 2 Diabetic Patients Undergoing Ambulatory Surgery: A Randomized Controlled Trial.
    Gasanova I; Meng J; Minhajuddin A; Melikman E; Alexander JC; Joshi GP
    Anesth Analg; 2018 Oct; 127(4):e54-e56. PubMed ID: 30044293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diabetes and cancer: a consensus report.
    Giovannucci E; Harlan DM; Archer MC; Bergenstal RM; Gapstur SM; Habel LA; Pollak M; Regensteiner JG; Yee D
    CA Cancer J Clin; 2010; 60(4):207-21. PubMed ID: 20554718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Safety is the issue again].
    Overbeck P
    MMW Fortschr Med; 2013 Oct; 155(17):26. PubMed ID: 24340377
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
    Pou Torelló JM; Vilaclara JM
    Rev Iber Endocrinol; 1974; 21(125):427-30, 433-8, 441-2 passim. PubMed ID: 4608666
    [No Abstract]   [Full Text] [Related]  

  • 40. [Behavior of lactate and pyruvate in diabetics during ambulatory treatment with biguanides or with a combination of biguanides and sulfonylureas. II].
    Lunetta M; Presti C; Mughini MT; Mughini L
    Clin Ter; 1980 Jun; 93(6):657-72. PubMed ID: 6775864
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.